Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines ...

Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalosporin ...

006280.KS GC Biopharma Corp.

[90] Common drugs associated with IgE-mediated allergies include b-lactam antibiotics (e.g., penicillin and cephalosporin), immunoglobulin preparations (IgA, IgE), pyrazolones, quinolones ...

Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...